Loading clinical trials...
Loading clinical trials...
Phase 1 Study of Pazopanib in Combination With Irinotecan and Temozolomide (PAZIT) for Children and Young Adults With Relapsed or Refractory Sarcoma
Conditions
Interventions
Pazopanib
Irinotecan
+1 more
Locations
3
United States
UCSF Benioff Children's Hospital, Oakland
Oakland, California, United States
University of California, San Francisco
San Francisco, California, United States
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Start Date
June 6, 2017
Primary Completion Date
October 15, 2019
Completion Date
September 30, 2020
Last Updated
January 5, 2021
NCT04704661
NCT06066138
NCT05039801
NCT07479732
NCT03715933
NCT07156565
Lead Sponsor
University of California, San Francisco
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions